Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (81-90 of 358) with videos related to

Pageof 36
Sort By:
Medicine|June 21, 2018
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case reportGerardo Rosati, Nunzio Del Gaudio, Enrico Scarano, et al.
Nature Reviews. Drug Discovery|October 2, 2007
RAR and RXR modulation in cancer and metabolic diseaseLucia Altucci, Mark D Leibowitz, Kathleen M Ogilvie, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agentsHong Su, Angela Nebbioso, Vincenzo Carafa, et al.
General and Comparative Endocrinology|August 27, 2013
Nuclear size as estrogen-responsive chromatin quality parameter of mouse spermatozoaGiovanna Cacciola, Teresa Chioccarelli, Lucia Altucci, et al.
International Journal of Endocrinology|April 8, 2020
Fetal-Perinatal Exposure to Bisphenol-A Affects Quality of Spermatozoa in Adulthood MouseTeresa Chioccarelli, Francesco Manfrevola, Marina Migliaccio, et al.
Biomed Research International|April 18, 2015
Corrigendum to "SIRT1 inhibition affects angiogenic properties of human MSCs"Chiara Botti, Ilaria Caiafa, Antonietta Coppola, et al.
Journal of Cellular Physiology|April 8, 2015
Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric SpeciesClara Iannuzzi, Vincenzo Carafa, Lucia Altucci, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Clinical Epigenetics|June 19, 2025
Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approachFederica Sarno, Jim J Jacob, Roos E Eilers, et al.
Pageof 36

Showing results (81-90 of 358) with videos related to

Sort By:
Pageof 36
Medicine|June 21, 2018
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case reportGerardo Rosati, Nunzio Del Gaudio, Enrico Scarano, et al.
Nature Reviews. Drug Discovery|October 2, 2007
RAR and RXR modulation in cancer and metabolic diseaseLucia Altucci, Mark D Leibowitz, Kathleen M Ogilvie, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agentsHong Su, Angela Nebbioso, Vincenzo Carafa, et al.
General and Comparative Endocrinology|August 27, 2013
Nuclear size as estrogen-responsive chromatin quality parameter of mouse spermatozoaGiovanna Cacciola, Teresa Chioccarelli, Lucia Altucci, et al.
International Journal of Endocrinology|April 8, 2020
Fetal-Perinatal Exposure to Bisphenol-A Affects Quality of Spermatozoa in Adulthood MouseTeresa Chioccarelli, Francesco Manfrevola, Marina Migliaccio, et al.
Biomed Research International|April 18, 2015
Corrigendum to "SIRT1 inhibition affects angiogenic properties of human MSCs"Chiara Botti, Ilaria Caiafa, Antonietta Coppola, et al.
Journal of Cellular Physiology|April 8, 2015
Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric SpeciesClara Iannuzzi, Vincenzo Carafa, Lucia Altucci, et al.
Epigenetics|October 5, 2020
Recent insights into <i>Histone Acetyltransferase-1</i>: biological function and involvement in pathogenesisAngelita Poziello, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Clinical Epigenetics|June 19, 2025
Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approachFederica Sarno, Jim J Jacob, Roos E Eilers, et al.
Pageof 36